Medicines

National Pharmacovigilance Centres

National Centres (NCs) are WHO-approved pharmacovigilance (PV) centres in countries participating in the WHO Programme for International Drug Monitoring. Healthcare professionals send adverse drug reaction (ADR) / individual case safety reports (ICSRs) to a regional or a NC. The latter (usually a part of or closely linked to the national drug regulatory agency) forwards the reports to the central WHO Global ICSR database that is managed and maintained by the UMC.

Every year representatives from the NCs meet and exchange common problems and solutions for promoting medicines safety.

back to the main page



Related publications

Share